PDAFX Performance — PGIM Target Date Income Fund, Class R3
Data updated: 2026-10-13
PDAFX returned +4.86% year to date and +9.57% over one year to Jul 2026. Annualised returns are +8.04% over 3 years and +3.67% over 5 years. The fund trailed its US Multi-Cap Blend category average: $100 invested three years ago grew to $126, against $139 for the category, and to $110 over one year, against $114. Volatility over the past three years was 5.97% a year. In the 12 months to Jul 2026 the fund lost a net $2.2M, and assets reached $24.06M.
PDAFX Growth of $100
What $100 invested in PGIM Target Date Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Blend category average over the same months.
| Period | PDAFX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $110 | $114 |
| 3 years (Aug 2023 – Jul 2026) | $126 | $139 |
| 5 years (Aug 2021 – Jul 2026) | $120 | $135 |
| Since data start (Aug 2019 – Jul 2026) | $144 | $172 |
PDAFX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.86% |
| 1 year | +9.57% |
| 3 years (annualised) | +8.04% |
| 5 years (annualised) | +3.67% |
PDAFX Annual Returns
Calendar-year total returns of PGIM Target Date Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +4.86% |
| 2025 | +10.16% |
| 2024 | +6.36% |
| 2023 | +8.65% |
| 2022 | −11.95% |
| 2021 | +9.05% |
| 2020 | +7.93% |
| 2019 (Aug–Dec) | +3.86% |
PDAFX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.6% | +1.8% | −2.3% | +3.4% | +0.8% | −0.4% | 0.0% | — | — | — | — | — |
| 2025 | +1.6% | +1.3% | −0.8% | +0.1% | +1.1% | +2.0% | +0.1% | +1.8% | +1.4% | +0.8% | +0.8% | −0.3% |
| 2024 | +0.1% | +0.5% | +1.6% | −2.4% | +2.5% | +0.9% | +1.8% | +1.7% | +1.7% | −2.0% | +1.8% | −1.9% |
| 2023 | +3.8% | −2.2% | +1.9% | +0.5% | −1.3% | +1.9% | +1.3% | −1.0% | −2.7% | −1.6% | +4.6% | +3.5% |
| 2022 | −2.2% | −0.6% | 0.0% | −3.8% | −0.2% | −4.5% | +4.6% | −2.8% | −6.5% | +2.0% | +4.0% | −2.0% |
| 2021 | −0.1% | +0.4% | +0.6% | +2.5% | +0.9% | +0.9% | +1.7% | +0.5% | −1.6% | +2.1% | −0.7% | +1.7% |
| 2020 | +0.6% | −2.1% | −7.0% | +4.5% | +2.2% | +1.6% | +2.7% | +1.8% | −1.3% | −1.1% | +4.4% | +1.9% |
| 2019 | — | — | — | — | — | — | — | +0.8% | +0.2% | +0.9% | +0.6% | +1.2% |
PDAFX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 5.97%
- 3-year Sharpe ratio: 0.59 (vs 4.5% risk-free rate)
- Best month: +4.60% (Nov 2023)
- Worst month: −2.66% (Sep 2023)
PDAFX Fund Flows
Monthly money in and out of PGIM Target Date Income Fund, from SEC Form N-PORT.
- 12-month net flow: −$2.2M
- 12-month gross sales (incl. reinvestments): $5.3M
- Sales ÷ redemptions: 0.70×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $53K | $724K | −$671K |
| Jun 2026 | $328K | $145K | $182K |
| May 2026 | $58K | $2.5M | −$2.5M |
| Apr 2026 | $164K | $85K | $80K |
| Mar 2026 | $179K | $1.5M | −$1.4M |
| Feb 2026 | $156K | $858K | −$702K |
| Jan 2026 | $56K | $208K | −$153K |
| Dec 2025 | $3.8M | $428K | $3.4M |
| Nov 2025 | $49K | $199K | −$150K |
| Oct 2025 | $15K | $150K | −$135K |
| Sep 2025 | $344K | $84K | $260K |
| Aug 2025 | $23K | $496K | −$473K |
PDAFX Assets Under Management
Net assets of PGIM Target Date Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $24.06M |
| 2026-04-30 | $27.20M |
| 2026-01-30 | $28.53M |
| 2025-10-31 | $25.50M |
| 2025-07-31 | $25.12M |
| 2025-04-30 | $25.13M |
| 2025-01-31 | $26.16M |
| 2024-10-31 | $16.51M |
| 2024-07-31 | $17.55M |
| 2024-04-30 | $18.16M |
| 2024-01-31 | $19.42M |
| 2023-10-31 | $21.12M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.